Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 18 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11629145

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  2. US 11622970

    BCL-2 inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  3. US 11623923

    Uracil compound as c-MET/AXL inhibitor

    Medshine Discovery Inc. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  4. US 11617742

    Methods of treating keratin hyperproliferation disorders using mTOR inhibitors

    PALVELLA THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  5. US 11618746

    Inhibitors of APOL1 and methods of using same

    Vertex Pharmaceuticals Incorporated · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  6. US 11618733

    Crystalline salts of a plasma kallikrein inhibitor

    BioCryst Pharmaceuticals, Inc. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  7. US 11618731

    Prodrugs of kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  8. US 11613527

    Enzyme inhibitors

    KalVista Pharmaceuticals Limited · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  9. US 11613528

    Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  10. US 11607414

    Small molecule inhibitors of EGFR and PI3K

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  11. US 11608346

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  12. US 11608354

    Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease

    Theravance Biopharma R&D IP, LLC · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  13. US 11597727

    Inhibitors of integrin alpha 2 beta 1 and methods of use

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted

  14. US 11596633

    SHP2 inhibitor compositions and methods for treating cancer

    Revolution Medicines, Inc. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted

  15. US 11590197

    Agents targeting inhibitor of apoptosis proteins

    The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  16. US 11591330

    HIF-2a small-molecule inhibitor and use thereof

    China Medical University · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  17. US 11591304

    SLC26A3 inhibitors and use thereof

    The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  18. US 11591336

    Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors

    Relay Therapeutics, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  19. US 11584758

    RIP1K inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  20. US 11584733

    Selective histone deacetylase inhibitors for the treatment of human disease

    Shuttle Pharmaceuticals, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  21. US 11584735

    Solid forms of a plasma kallikrein inhibitor and salts thereof

    KalVista Pharmaceuticals Limited · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  22. US 11583538

    Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors

    VENENUM BIODESIGN, LLC · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  23. US 11576948

    Long-acting VEGF inhibitors for intraocular neovascularization

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  24. US 11576922

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.